XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) has partnered with a company called 3a-Diagnostics to develop a rapid disposable COVID-19 test.
Work has progressed so rapidly in recent weeks the pair are targeting regulatory approval for the product in the first three months of next year.
Bringing us up to date on progress with areas such as advanced prototype production and usability testing will be CEO Hugh Rogers.
Catch up with Hugh at the Proactive Virtual Forum on Tuesday October 27, from 1pm EST.
About the event:
- Ours is an audience of astute high net worth investors, fund managers, private client brokers and analysts
- We look beyond the numbers and meet the people creating the value for shareholders
- Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story
- You can watch the event afterwards on our YouTube channel